Acquisition pumps up lab stock

  • By Business Observer Staff
  • | 1:19 p.m. April 28, 2016
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — Cancer-testing laboratory NeoGenomics posted 159% quarterly revenue growth, boosted by its recent acquisition of rival Clarient from GE Healthcare.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • April 3, 2026
Bradenton restaurant to open second spot, in south Sarasota County
  • April 3, 2026
Net-zero Cortez community selects company to handle rentals
  • April 2, 2026
Sarasota Doctors Hospital names new COO
  • April 2, 2026
Babcock Ranch shopping center gets refinance

Sponsored Content